These data suggest the possibility that Irs1-mediated signalling is enhanced, whereas Irs2-mediated signalling is impaired in the livers in the cases of type 2 diabetes and obesity. Here, IRS2 is linked to obesity due to melanocortin 4 receptor deficiency.